A study by Stjepanovic et al also found that premenopausal RRSBO decreased short term risk of breast cancer in BRCA1 mutation carriers, though longer follow-up and larger sample size is needed to determine the potential benefit in BRCA2 carriers [91]. This evidence concerns the gene BRCA2 and breast carcinoma.